Skip to main content

Table 4 Survival analysis. Proportional hazards model containing FVC, age and gender as covariates

From: Pirfenidone improves survival in IPF: results from a real-life study

  HR 95% CI P value
Centre 0.28 0.16, 0.48 P<0.0001
Gender 1.96 1.19, 3.22 P<0.008
Age 1.03 1.01, 1.05 P<0.002
FVC 0.97 0.96, 0.98 P<0.0001